UNSPSC 51402001: Emylcamate

This classification denotes an anxiolytic with the molecular formula C7H15NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KCJ747D3R4, chemically known as 3-pentanol, 3-methyl-, carbamate (8ci)(9ci) but generally known as emylcamate, which bears US NIH Compound Identifier 6526. European Medicines Agency schedules Emylcamate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06512MIG.

UNSPSC 51402001 Emylcamate is a Commodity code that in recent state and local procurement activity tracks purchases of naloxone and drug deactivation systems for community health support. State and local governments use this code to procure pharmaceutical and medical supplies tied to opioid response and harm-reduction initiatives, with issuing bodies including county health departments and community health agencies. The scope of work encompasses the acquisition of finished pharmaceutical products and medical devices in quantities sufficient to support ongoing public health programs, including quarterly or routine deliveries to designated facilities.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract carries a two-year initial term with a one-year renewal option and was potentially funded through FEMA. Vendors must comply with drug-free workplace certification, E-Verify requirements, and specified insurance coverage, with pricing on a fixed-fee basis. Recent activity under this code is limited, with the Seminole County opportunity representing the primary visible state and local procurement signal in the current window.